Effects of inulin on faecal bifidobacteria in human subjects - PubMed (original) (raw)
Clinical Trial
Effects of inulin on faecal bifidobacteria in human subjects
H P Kruse et al. Br J Nutr. 1999 Nov.
Abstract
A controlled study with eight healthy free-living subjects was carried out, in which energy intake was adjusted to the individual energy requirements. On administration of inulin, blood lipids, the faecal microflora, short-chain fatty acids and accompanying gastrointestinal symptoms were characterized in order to investigate the long-term effect of inulin. During the run-in phase (8 d), subjects received a typical Western diet providing 45% energy as fat and 40% energy as carbohydrate. Subsequently, the subjects consumed a fat-reduced diet which provided 30% energy as fat and 55% energy as carbohydrate for a period of 64 d using inulin as a fat replacer. The amounts of inulin consumed by the subjects (up to 34 g/d) were based on individual energy requirements with the aim to keep the diet isoenergetic with that used in the run-in period. To assess the effects of inulin administration, a control study (run-in and intervention) was carried out in which subjects consumed the same diet but devoid of inulin during the whole course of the study. To investigate the effect of inulin on faecal flora composition total bacteria and bifidobacteria in the faeces were enumerated by in situ hybridization with 16S rRNA targeted oligonucleotide probes. Inulin significantly increased bifidobacteria from 9.8 to 11.0 log10/g dry faeces and caused a moderate increase in gastrointestinal symptoms such as flatulence and bloatedness, whereas blood lipids and short-chain fatty acids remained essentially unaffected.
Similar articles
- Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora.
Kleessen B, Hartmann L, Blaut M. Kleessen B, et al. Br J Nutr. 2001 Aug;86(2):291-300. doi: 10.1079/bjn2001403. Br J Nutr. 2001. PMID: 11502244 - Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin.
Gibson GR, Beatty ER, Wang X, Cummings JH. Gibson GR, et al. Gastroenterology. 1995 Apr;108(4):975-82. doi: 10.1016/0016-5085(95)90192-2. Gastroenterology. 1995. PMID: 7698613 - The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population.
Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. Fava F, et al. Int J Obes (Lond). 2013 Feb;37(2):216-23. doi: 10.1038/ijo.2012.33. Epub 2012 Mar 13. Int J Obes (Lond). 2013. PMID: 22410962 Clinical Trial. - Introducing inulin-type fructans.
Roberfroid MB. Roberfroid MB. Br J Nutr. 2005 Apr;93 Suppl 1:S13-25. doi: 10.1079/bjn20041350. Br J Nutr. 2005. PMID: 15877886 Review. - [Inulin--potential prebiotic].
Sokiić ZB, Knezević J, Vrvić MM. Sokiić ZB, et al. Med Pregl. 2009 Mar-Apr;62(3-4):153-6. doi: 10.2298/mpns0904153s. Med Pregl. 2009. PMID: 19623846 Review. Serbian.
Cited by
- Supplemental dietary inulin of variable chain lengths alters intestinal bacterial populations in young pigs.
Patterson JK, Yasuda K, Welch RM, Miller DD, Lei XG. Patterson JK, et al. J Nutr. 2010 Dec;140(12):2158-61. doi: 10.3945/jn.110.130302. Epub 2010 Oct 27. J Nutr. 2010. PMID: 20980641 Free PMC article. - Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut.
Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ. Belenguer A, et al. Appl Environ Microbiol. 2006 May;72(5):3593-9. doi: 10.1128/AEM.72.5.3593-3599.2006. Appl Environ Microbiol. 2006. PMID: 16672507 Free PMC article. - A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects.
Ramnani P, Costabile A, Bustillo AG, Gibson GR. Ramnani P, et al. J Nutr Sci. 2015 Mar 13;4:e10. doi: 10.1017/jns.2014.68. eCollection 2015. J Nutr Sci. 2015. PMID: 26090092 Free PMC article. - Comparative analysis of prebiotic effects of four oligosaccharides using in vitro gut model: digestibility, microbiome, and metabolome changes.
Cheon S, Kim G, Bae JH, Lee DH, Seong H, Kim DH, Han JS, Lim SY, Han NS. Cheon S, et al. FEMS Microbiol Ecol. 2023 Jan 24;99(2):fiad002. doi: 10.1093/femsec/fiad002. FEMS Microbiol Ecol. 2023. PMID: 36623850 Free PMC article. - Changes in infants faecal characteristics and microbiota by inulin supplementation.
K W Yap W, Mohamed S, Husni Jamal M, Diederick M, A Manap Y. K W Yap W, et al. J Clin Biochem Nutr. 2008 Nov;43(3):159-66. doi: 10.3164/jcbn.2008055. Epub 2008 Oct 31. J Clin Biochem Nutr. 2008. PMID: 19015750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical